Search Results - "SELLERS, Mark V"
-
1
Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non–Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial
Published in Journal of clinical oncology (10-02-2010)“…PURPOSE In the phase III INTEREST trial, 1,466 pretreated patients with advanced non-small cell lung cancer (NSCLC) were randomly assigned to receive gefitinib…”
Get full text
Journal Article -
2
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
Published in The Lancet (British edition) (22-11-2008)“…Summary Background Two phase II trials in patients with previously-treated advanced non-small-cell lung cancer suggested that gefitinib was efficacious and…”
Get full text
Journal Article -
3
Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study
Published in Radiotherapy and oncology (01-07-2011)“…Abstract Background and purpose To assess the efficacy and safety of gefitinib given concomitantly and/or as maintenance therapy to standard…”
Get full text
Journal Article -
4